[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 19 Introduced in Senate (IS)]
107th CONGRESS
1st Session
S. RES. 19
To express the sense of the Senate that the Federal investment in
biomedical research should be increased by $3,400,000,000 in fiscal
year 2002.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
February 13, 2001
Mr. Specter (for himself, Mr. Harkin, Ms. Mikulski, Mr. Frist, Mr.
Schumer, Mr. Sarbanes, Ms. Collins, Mr. DeWine, Mr. Hutchinson, Ms.
Snowe, Mr. Cochran, Mr. Santorum, and Mrs. Murray) submitted the
following resolution; which was referred to the Committee on
Appropriations
_______________________________________________________________________
RESOLUTION
To express the sense of the Senate that the Federal investment in
biomedical research should be increased by $3,400,000,000 in fiscal
year 2002.
Whereas past investments in biomedical research have resulted in better health,
an improved quality of life for all Americans and a reduction in
national health care expenditures;
Whereas the Nation's commitment to biomedical research has expanded the base of
scientific knowledge about health and disease and revolutionized the
practice of medicine;
Whereas the Federal Government represents the single largest contribution to
biomedical research conducted in the United States;
Whereas biomedical research continues to play a vital role in the growth of this
Nation's biotechnology, medical device, and pharmaceutical industries;
Whereas the origin of many of the new drugs and medical devices currently in use
is based in biomedical research supported by the National Institutes of
Health;
Whereas women have traditionally been under represented in medical research
protocols, yet are severely affected by diseases including breast
cancer, claimed the lives of 40,800 women last year; ovarian cancer
claimed another 14,000 lives; and osteoporosis and cardiovascular
disorders;
Whereas research sponsored by the National Institutes of Health is responsible
for the identification of genetic mutations relating to nearly 100
diseases, including Alzheimer's disease, cystic fibrosis, Huntington's
disease, osteoporosis, many forms of cancer, and immune deficiency
disorders;
Whereas many Americans still face serious and life-threatening health problems;
both acute and chronic;
Whereas neurodegenerative diseases of the elderly, such as Alzheimer's and
Parkinson's disease threaten to destroy the lives of millions of
Americans, overwhelm the Nation's health care system, and bankrupt the
Medicare and Medicaid programs;
Whereas one in one hundred Americans is currently infected with the hepatitis C
virus, an insidious liver condition that can lead to inflammation,
cirrhosis, and cancer as well as liver failure;
Whereas 320,000 Americans are now suffering from AIDS and hundreds of thousands
more with HIV infection;
Whereas cancer remains a comprehensive threat to any tissue or organ of the body
at any age, and remains a leading cause of morbidity and mortality;
Whereas the extent of psychiatric and neurological diseases poses considerable
challenges in understanding the workings of the brain and nervous
system;
Whereas recent advances in the treatment of HIV illustrate the promise research
holds for even more effective, accessible, and affordable treatments for
persons with HIV;
Whereas infants and children are the hope of our future, yet they continue to be
the most vulnerable and under served members of our society;
Whereas prostate cancer is the second leading cause of cancer deaths in men and
last year 31,900 men died from prostate cancer;
Whereas diabetes, both insulin and non-insulin forms, afflict 16 million
Americans and places them at risk for acute and chronic complications,
including blindness, kidney failure, atherosclerosis and nerve
degeneration;
Whereas the emerging understanding of the principles of biomimetrics have been
applied to the development of hard tissue such as bone and teeth as well
as soft tissue, and this field of study holds great promise for the
design of new classes of biomaterials, pharmaceuticals, diagnostic and
analytical reagents;
Whereas research sponsored by the National Institutes of Health will map and
sequence the entire human genome by 2003, leading to a new era of
molecular medicine that will provide unprecedented opportunities for the
prevention, diagnoses, treatment, and cure of diseases that currently
plague society;
Whereas the fundamental way science is conducted is changing at a revolutionary
pace, demanding a far greater investment in emerging new technologies,
research training programs, and in developing new skills among
scientific investigators; and
Whereas most Americans show overwhelming support for an increased Federal
investment in biomedical research: Now, therefore, be it
Resolved,
SECTION 1. SHORT TITLE.
This resolution may be cited as the ``Biomedical Revitalization
Resolution of 2001''.
SEC. 2. SENSE OF THE SENATE.
It is the sense of the Senate that funding for the National
Institutes of Health should be increased by $3,400,000,000 in fiscal
year 2002 and that the budget resolution appropriately reflect
sufficient funds to achieve this objective.
<all>